ALL libraries (COBIB.SI union bibliographic/catalogue database)
  • Zdravljenje s krvnimi pripravki pri kritično bolnih gastroenteroloških bolnikih
    Borovšak, Zvonko
    Introduction. Immediately after patients with severe head injury, critically ill gastroterological patients (CIGP) represent the second largest group of patients in the ICU. Treatment of CIGP with ... blood preparations is an everyday challenge since their use in these patients is most often unjustified and pointless. Patients. CIGP are those with gastroenterological diseases that fulfill the criteria for critical diseases as evaluated by one of the point systems for disease evaluation (APACHE II). They differ from other critically ill patients by their greater susceptibility to inflammation, which mostly leads to sepsis and multiorgan failure. The cause lies in the affection of theintestinal mucosa and the transition of bacteria from the intestinal lumen to the lymph nodes. The ensuing inflammation stimulates disturbances in coagulation stimulation. Conclusions. The course of treatment for CIGP is the same as in other critical cases in the ICU. The guidelines for thrombocyte replacement are established and no major deviations occur during the replacement. The use of fresh frozen plasma is increasing regardless of clearindications and of the fact that in at least one third of cases its use is unjustified. Studies have caused some confusion in the field of albumin replacement, so the decisions regarding replacement are left entirely to the judgment of the physician. Fibrinogen is replaced only rarely, and in agreement with a transfusiologist. The use of antithrombin III is decreasing in accordance with guidelines and is strictly monitored. Activated recombinantfactor VIIa is used in cases of uncontrollable hemorrhage and according to protocol. In CIGP the consideration of guidelines for treatment with blood preparations decreases the possibility of misuse of a biological remedy. The decisions regarding the justification - usefulness of applying plasma components are made by the physician at the patients bedside.
    Type of material - conference contribution
    Publish date - 2005
    Language - slovenian
    COBISS.SI-ID - 21560793